150 related articles for article (PubMed ID: 32189555)
21. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
22. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
[TBL] [Abstract][Full Text] [Related]
23. Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.
Habteyesus A; Nordenskjöld A; Bohman C; Eriksson S
Biochem Pharmacol; 1991 Oct; 42(9):1829-36. PubMed ID: 1657002
[TBL] [Abstract][Full Text] [Related]
24. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
Fyrberg A; Albertioni F; Lotfi K
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
[TBL] [Abstract][Full Text] [Related]
25. New insights into the synergism of nucleoside analogs with radiotherapy.
Lee MW; Parker WB; Xu B
Radiat Oncol; 2013 Sep; 8():223. PubMed ID: 24066967
[TBL] [Abstract][Full Text] [Related]
26. Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC).
Kroep JR; van Moorsel CJ; Veerman G; Voorn DA; Schultz RM; Worzalla JF; Tanzer LR; Merriman RL; Pinedo HM; Peters GJ
Adv Exp Med Biol; 1998; 431():657-60. PubMed ID: 9598147
[No Abstract] [Full Text] [Related]
27. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
Nielsen SE; Munch-Petersen B; Mejer J
Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
[TBL] [Abstract][Full Text] [Related]
28. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation.
Knecht W; Petersen GE; Munch-Petersen B; Piskur J
J Mol Biol; 2002 Jan; 315(4):529-40. PubMed ID: 11812127
[TBL] [Abstract][Full Text] [Related]
29. Nucleoside Analog Activity in Malignant Melanoma Cell Lines.
Fyrberg A; Lotfi K
Nucleosides Nucleotides Nucleic Acids; 2015; 34(9):639-49. PubMed ID: 26252632
[TBL] [Abstract][Full Text] [Related]
30. Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro.
Grégoire V; Rosier JF; De Bast M; Bruniaux M; De Coster B; Octave-Prignot M; Scalliet P
Radiother Oncol; 2002 Jun; 63(3):329-38. PubMed ID: 12142097
[TBL] [Abstract][Full Text] [Related]
31. Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities.
Stålhandske P; Wang L; Westberg S; von Euler H; Groth E; Gustafsson SA; Eriksson S; Lennerstrand J
Anal Biochem; 2013 Jan; 432(2):155-64. PubMed ID: 22902741
[TBL] [Abstract][Full Text] [Related]
32. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
33. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of mRNA specific for thymidine kinase, deoxycytidine kinase or thymidine phosphorylase in human papillary thyroid carcinoma.
Karbownik M; Brzezianska E; Lewinski A
Cancer Lett; 2005 Jul; 225(2):267-73. PubMed ID: 15978330
[TBL] [Abstract][Full Text] [Related]
35. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
Turriziani O; Butera O; Gianotti N; Parisi SG; Mazzi R; Girardi E; Iaiani G; Antonelli L; Lazzarin A; Antonelli G
AIDS; 2005 Mar; 19(5):473-9. PubMed ID: 15764852
[TBL] [Abstract][Full Text] [Related]
37. The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues.
Hazra S; Konrad M; Lavie A
J Med Chem; 2010 Aug; 53(15):5792-800. PubMed ID: 20684612
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of isocarbostyril- and difluorophenyl-nucleoside thymidine mimics by the human deoxynucleoside kinases.
Al-Madhoun AS; Eriksson S; Wang ZX; Naimi E; Knaus EE; Wiebe LI
Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1865-74. PubMed ID: 15628745
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide specificity of human deoxycytidine kinase.
Shewach DS; Reynolds KK; Hertel L
Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
[TBL] [Abstract][Full Text] [Related]
40. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs.
Beauséjour CM; Tremblay G; Momparler RL
Biochem Biophys Res Commun; 2000 Nov; 278(3):569-75. PubMed ID: 11095951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]